Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of the Safety and Antiretroviral Activity of Nine Hydroxyurea Regimens in Combination With ddI and d4T in Subjects With HIV Infection

NCT00002427 is registered in ClinicalTrials.gov with Research Institute for Genetic and Human Therapy as lead sponsor.

NCT NCT00002427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of the Safety and Antiretroviral Activity of Nine Hydroxyurea Regimens in Combination With ddI and d4T in Subjects With HIV Infection
Lead sponsor
Research Institute for Genetic and Human Therapy
Phase
Phase 1
Overall status
Completed
Start date
May 31, 1999
Completion date
Not reported
Enrollment
225
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections